THE RATE OF POSITIVE CONVERSION IN THE QUANTIFERON-TB GOLD TEST OVER 2 YEARS AMONG PATIENTS TREATED WITH CT-P13 OR INNOVATOR INFLIXIMAB IN THE EXTENSION STUDIES OF PLANETAS AND PLANETRA
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.